These results indicate that manidipine selectively enhances the cytotoxic effects of P-gp substrate drugs in a dose-dependent manner in ABCB1-overexpressing MDR cancer cells, supporting its potential as a potent MDR reversal agent in vitro. Here, PGP is linked to cancer.